Search Results - technology+classifications+%3e+life+sciences+%3e+vaccines

3 Results Sort By:
Artificial Intelligence Model for Prediction of Optimal Peptide Binding to Specific MHC Alleles
This technology is an artificial intelligence (AI) software platform that predicts which tumor-derived peptides are most likely to bind to a patient’s specific major histocompatibility complex (MHC) alleles. By combining tumor sequencing data with patient-specific MHC profiles, the model helps identify neoantigens for personalized cancer vaccine...
Published: 7/22/2026   |   Updated: 7/22/2026   |   Inventor(s): Michael Kuhns, Ryan Sprissler, Ryan Gutenkunst, Heng Wu
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Vaccines, Technology Classifications > Software & Information Technology > Health IT
TROVE: A Translational Resource for Omics-Based Validation of Expression Datasets
Translational Resource for Omics-Based Validation of Expression (TROVE) is a solution-oriented query-able disease database that integrates various -omic data from animals and humans, reflective of the One Health paradigm. The innovation is focused on dataset integration and identification, to immediately provide targeted solutions for identified infection/immunity...
Published: 7/24/2023   |   Updated: 7/24/2023   |   Inventor(s): Gayatri Vedantam, Virinchipuram Viswanathan, Bryan Roxas
Keywords(s):  
Category(s): Technology Classifications > Software & Information Technology > Bioinformatics, Technology Classifications > Software & Information Technology > Health IT, Technology Classifications > Software & Information Technology, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Life Sciences > Vaccines
Cytomegalovirus Vaccine Backbone that Cannot be Reactivated
This technology describes a Cytomegalovirus (CMV) vaccine vector with mutations or deletions in newly-found intronic promoters that are important for CMV reactivation. Background: Cytomegalovirus (CMV) is a virus within the herpes family that is extremely common. Nearly 50% of adults will have contracted CMV by the time they reach 40 years old. Once...
Published: 4/14/2023   |   Updated: 7/16/2018   |   Inventor(s): Felicia Goodrum Sterling, Nathaniel Moorman, Jeremy Kamil
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Vaccines